Cytosorbents Crp (CTSO) financials · rev $37.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cytosorbents Crp (CTSO) rev $37.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $37.1M | $35.6M |
| Cost of Revenue | $10.6M | $10.5M |
| Gross Profit | $26.5M | $25.1M |
| Operating Income | -$14.7M | -$16.8M |
| Net Income | -$8.20M | -$20.7M |
| EPS (Diluted) | -$0.13 | -$0.38 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $44.2M | $47.4M |
| Current Assets | $20.6M | $21.6M |
| Cash & Equivalents | $6.25M | $3.28M |
| Inventory | $5.28M | $2.73M |
| PP&E | $7.82M | $9.00M |
| Total Liabilities | $38.3M | $36.3M |
| Current Liabilities | $9.71M | $9.82M |
| Long-term Debt | $16.7M | $14.0M |
| Total Debt | $16.7M† | $14.0M† |
| Shareholders' Equity | $5.90M | $11.1M |
| Retained Earnings | -$312.2M | -$304.0M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.4M | -$14.4M |
| CapEx | $164.0K | $284.3K |
| Investing Cash Flow | -$415.0K | -$669.4K |
| Financing Cash Flow | $9.31M | $9.33M |
| Net Change in Cash | -$1.99M | -$5.85M |
| Free Cash Flow | -$12.5M | -$14.7M |
FAQ
What is CTSO P/E and revenue?
Cytosorbents Crp (CTSO) rev $37.1M.
What is CTSO revenue?
Cytosorbents Crp last cached revenue is $37.1M (FY2025).
Is CTSO profitable?
Cytosorbents Crp last cached net income is -$8.20M (FY2025).
What are CTSO total assets?
Cytosorbents Crp last cached total assets are $44.2M (FY2025).
What is CTSO free cash flow?
Cytosorbents Crp last cached free cash flow is -$12.5M (FY2025).
Not investment advice. Cached statements, not a live tape.